Oppenheimer Weighs in on Milestone Pharmaceuticals Inc.’s FY2026 Earnings (NASDAQ:MIST)
Milestone Pharmaceuticals Inc. (NASDAQ:MIST – Get Rating) – Equities research analysts at Oppenheimer issued their FY2026 EPS estimates for shares of Milestone Pharmaceuticals in a research report…